Latest News from: Sbarro Health Research Organization (SHRO)

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 112
SBA_logo.png

Article ID: 714389

New Natural Therapeutic Agent to Fight Diabetic Nephropathy

Sbarro Health Research Organization (SHRO)

The extract successfully restored the blood glucose levels, body weight, and normalized oxidative stress on renal function in a test group of Zucker diabetic fatty rats.

Released:
14-Jun-2019 11:05 AM EDT

Article ID: 714260

Exploiting RB1 Predictive Value for Cancer Therapy in the Clinical Setting: Lost in Translation

Sbarro Health Research Organization (SHRO)

RB1 status has emerged not only as a key factor in cancer development and progression, but also as a crucial determinant of cell fate in response to various anticancer treatments

Released:
11-Jun-2019 4:10 PM EDT
SBA_logo.png

Article ID: 713887

Cervical Cancer During Pregnancy, Though Serious, is Highly Treatable According to New Research Review

Sbarro Health Research Organization (SHRO)

“Individualized therapies are strongly recommended and the treatment decision should be made collaboratively with a multidisciplinary team consisting of obstetricians, gynecologists, oncologists, pediatricians, and psychologists,” says researcher.

Released:
4-Jun-2019 9:55 AM EDT

Article ID: 713126

Brain Cancer Drug Reactivates Body's Natural Defenses

Sbarro Health Research Organization (SHRO)

Drug reactivates p53 tumor suppressor protein and increases chemotherapy effectiveness in potential glioblastoma breakthrough.

Released:
20-May-2019 4:05 AM EDT
Newswise: Enzyme Inhibition May Lead to New Melanoma Therapy, Say Researchers at Fox Chase with Support from Sbarro Institute

Article ID: 711087

Enzyme Inhibition May Lead to New Melanoma Therapy, Say Researchers at Fox Chase with Support from Sbarro Institute

Sbarro Health Research Organization (SHRO)

Inhibition of the cellular enzyme thymine DNA glycosylase (TDG) may be an effective treatment for melanoma, according to research published in the journal Oncogene in January. The paper, “Thymine DNA glycosylase as a novel target for melanoma,” describes how inhibition of TDG, known for its role in cell repair and proliferation, may be used to trigger cell death of cancerous melanoma cells and halt tumor growth.

Released:
10-Apr-2019 12:05 PM EDT
Newswise: Decoy Damaged DNA Discovers New Gene Repair Protein

Article ID: 709557

Decoy Damaged DNA Discovers New Gene Repair Protein

Sbarro Health Research Organization (SHRO)

A synthetic DNA structure was used as bait to capture nuclear proteins, revealing previously unknown role of HNRNPD in the cellular response to DNA damage.

Released:
14-Mar-2019 9:00 AM EDT
SBA_logo.png

Article ID: 707468

Potential to Better Treat Mesothelioma Revealed by Precision Medicine Research

Sbarro Health Research Organization (SHRO)

Researchers have successfully identified two genetic markers for potentially effective treatment of Mesothelioma, an orphan disease most commonly associated with asbestos exposure, and for which few treatments exist.

Released:
4-Feb-2019 11:45 AM EST
SBA_logo.png

Article ID: 705220

Metastatic Breast Cancer Survival Improves with New CDK-Inhibitor Plus Endocrine Therapy

Sbarro Health Research Organization (SHRO)

A study finds that palbociclib, in combination with endocrine therapy, improves progression free survival

Released:
11-Dec-2018 7:55 AM EST

Showing results

110 of 112

Chat now!